vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3M vs $336.6M, roughly 1.1× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 4.0% vs -3.6%, a 7.6% gap on every dollar of revenue. On growth, Guardian Pharmacy Services, Inc. posted the faster year-over-year revenue change (2.2% vs -4.7%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

CLW vs GRDN — Head-to-Head

Bigger by revenue
CLW
CLW
1.1× larger
CLW
$360.3M
$336.6M
GRDN
Growing faster (revenue YoY)
GRDN
GRDN
+6.9% gap
GRDN
2.2%
-4.7%
CLW
Higher net margin
GRDN
GRDN
7.6% more per $
GRDN
4.0%
-3.6%
CLW

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLW
CLW
GRDN
GRDN
Revenue
$360.3M
$336.6M
Net Profit
$-12.8M
$13.5M
Gross Margin
-0.2%
22.7%
Operating Margin
5.3%
Net Margin
-3.6%
4.0%
Revenue YoY
-4.7%
2.2%
Net Profit YoY
-103.2%
46.1%
EPS (diluted)
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
GRDN
GRDN
Q1 26
$360.3M
$336.6M
Q4 25
$386.4M
$397.6M
Q3 25
$399.0M
$377.4M
Q2 25
$391.8M
$344.3M
Q1 25
$378.2M
$329.3M
Q4 24
$387.1M
Q3 24
$393.3M
$314.4M
Q2 24
$344.4M
Net Profit
CLW
CLW
GRDN
GRDN
Q1 26
$-12.8M
$13.5M
Q4 25
$38.3M
$20.9M
Q3 25
$-53.3M
$9.8M
Q2 25
$2.7M
$9.0M
Q1 25
$-6.3M
$9.4M
Q4 24
$199.1M
Q3 24
$5.8M
$-122.0M
Q2 24
$-25.8M
Gross Margin
CLW
CLW
GRDN
GRDN
Q1 26
-0.2%
22.7%
Q4 25
4.5%
21.5%
Q3 25
4.7%
19.8%
Q2 25
11.0%
19.8%
Q1 25
9.7%
19.5%
Q4 24
3.8%
Q3 24
7.7%
19.4%
Q2 24
-0.6%
Operating Margin
CLW
CLW
GRDN
GRDN
Q1 26
5.3%
Q4 25
1.9%
7.7%
Q3 25
-13.9%
4.3%
Q2 25
2.5%
3.7%
Q1 25
-1.1%
3.9%
Q4 24
-4.0%
Q3 24
-0.3%
-33.3%
Q2 24
-13.6%
Net Margin
CLW
CLW
GRDN
GRDN
Q1 26
-3.6%
4.0%
Q4 25
9.9%
5.3%
Q3 25
-13.4%
2.6%
Q2 25
0.7%
2.6%
Q1 25
-1.7%
2.9%
Q4 24
51.4%
Q3 24
1.5%
-38.8%
Q2 24
-7.5%
EPS (diluted)
CLW
CLW
GRDN
GRDN
Q1 26
$0.21
Q4 25
$2.36
Q3 25
$-3.30
Q2 25
$0.17
Q1 25
$-0.38
Q4 24
$11.87
Q3 24
$0.35
Q2 24
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$36.5M
$64.9M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$813.8M
$232.4M
Total Assets
$1.6B
$426.9M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
GRDN
GRDN
Q1 26
$36.5M
$64.9M
Q4 25
$30.7M
$65.6M
Q3 25
$34.4M
$36.5M
Q2 25
$46.7M
$18.8M
Q1 25
$44.0M
$14.0M
Q4 24
$79.6M
Q3 24
$35.5M
$37.2M
Q2 24
$39.6M
Total Debt
CLW
CLW
GRDN
GRDN
Q1 26
$361.1M
Q4 25
$346.8M
$0
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
Q3 24
$1.2B
$34.3M
Q2 24
$1.1B
Stockholders' Equity
CLW
CLW
GRDN
GRDN
Q1 26
$813.8M
$232.4M
Q4 25
$825.3M
$217.9M
Q3 25
$783.0M
$195.5M
Q2 25
$836.8M
$179.7M
Q1 25
$836.6M
$163.2M
Q4 24
$854.6M
Q3 24
$664.6M
$133.9M
Q2 24
$658.6M
Total Assets
CLW
CLW
GRDN
GRDN
Q1 26
$1.6B
$426.9M
Q4 25
$1.6B
$412.7M
Q3 25
$1.6B
$390.0M
Q2 25
$1.6B
$356.3M
Q1 25
$1.6B
$334.0M
Q4 24
$1.7B
Q3 24
$2.5B
$348.0M
Q2 24
$2.5B
Debt / Equity
CLW
CLW
GRDN
GRDN
Q1 26
0.44×
Q4 25
0.42×
0.00×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
Q3 24
1.73×
0.26×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
GRDN
GRDN
Operating Cash FlowLast quarter
$6.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.45×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$5.0M
$34.6M
Q3 25
$34.0M
$28.2M
Q2 25
$-28.2M
$19.9M
Q1 25
$1.5M
$17.6M
Q4 24
$-35.1M
Q3 24
$16.2M
Q2 24
$21.1M
Free Cash Flow
CLW
CLW
GRDN
GRDN
Q1 26
Q4 25
$-9.9M
Q3 25
$15.7M
$24.2M
Q2 25
$-51.1M
Q1 25
$-31.2M
Q4 24
$-68.1M
Q3 24
$-30.8M
Q2 24
$3.0M
FCF Margin
CLW
CLW
GRDN
GRDN
Q1 26
Q4 25
-2.6%
Q3 25
3.9%
6.4%
Q2 25
-13.0%
Q1 25
-8.2%
Q4 24
-17.6%
Q3 24
-7.8%
Q2 24
0.9%
Capex Intensity
CLW
CLW
GRDN
GRDN
Q1 26
Q4 25
3.9%
Q3 25
4.6%
1.1%
Q2 25
5.8%
Q1 25
8.6%
Q4 24
8.5%
Q3 24
12.0%
Q2 24
5.3%
Cash Conversion
CLW
CLW
GRDN
GRDN
Q1 26
0.45×
Q4 25
0.13×
1.65×
Q3 25
2.87×
Q2 25
-10.44×
2.21×
Q1 25
1.86×
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons